Jane Street Group, LLC Marker Therapeutics, Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.24 - $4.58 $2,969 - $56,672	12,374 New	12,374 $3,000
Q2 2022 Aug 16, 2022	BUY	$0.26 - $0.46 $16,999 - $30,076	65,384 New	65,384 $22,000
Q1 2022 May 17, 2022	SELL	$0.37 - $1.0 $31,515 - $85,177	-85,177 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.95 - $1.72 $56,990 - $103,182	59,990 Added 238.18%	85,177 $81,000
Q2 2021 Aug 16, 2021	BUY	$1.88 - $3.56 $787 - $1,491	419 Added 1.69%	25,187 $70,000
Q1 2021 May 18, 2021	BUY	$1.47 - $3.29 $36,408 - $81,486	24,768 New	24,768 $55,000
Q4 2020 Feb 17, 2021	SELL	$1.36 - $1.75 $33,197 - $42,717	-24,410 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.5 - $2.2 $36,615 - $53,702	24,410 New	24,410 $37,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $255M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.